Triple
T13959265
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Gamaleya Research Institute |
E335748
|
entity |
| Predicate | developed |
P73
|
FINISHED |
| Object | Sputnik V |
E1071419
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Sputnik V | Statement: [Gamaleya Research Institute, developed, Sputnik V]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sputnik V Context triple: [Gamaleya Research Institute, developed, Sputnik V]
-
A.
Sputnik V COVID-19 vaccine
chosen
Sputnik V COVID-19 vaccine is a Russian-developed viral vector vaccine against COVID-19 that gained global attention as one of the first vaccines authorized for use during the pandemic.
-
B.
Sinovac
Sinovac is a Chinese biopharmaceutical company best known globally for developing the inactivated COVID-19 vaccine CoronaVac.
-
C.
CoronaVac
CoronaVac is an inactivated-virus COVID-19 vaccine developed by the Chinese biopharmaceutical company Sinovac Biotech and widely used in global vaccination campaigns.
-
D.
Comirnaty
Comirnaty is the brand name of the Pfizer–BioNTech mRNA COVID-19 vaccine used worldwide for the prevention of coronavirus infection.
-
E.
Vaxzevria COVID-19 vaccine
Vaxzevria COVID-19 vaccine is a viral vector coronavirus vaccine created to prevent COVID-19 infection and severe disease in adults.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c61f3508190aaf2ca0dc0002c59 |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e7b2f908190aa32f22298964746 |
completed | April 14, 2026, 12:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69fcb64df57c8190bc402c5ec268eaac |
completed | May 7, 2026, 3:57 p.m. |
Created at: April 9, 2026, 10:17 p.m.